No one wants to miss a holiday, birthday, or other special celebrations with family and friends. For women with early stage breast cancer there may be options, but choosing the best option is critical.
Patient-focused, physician-inspired solutions from the market leader in APBI.
The MSML can meet all of the requirements set forth by the recent NSABP B-39 protocol amendment. Essentially, these criteria address the following dosimetric minimal standards that must be met concurrently:
| 1. |
≥90% of the prescribed dose (PD) ≥90% of the target volume (PTV_EVAL)
|
| 2. |
Maximum skin dose ≤ 145% of the PD
|
| 3. |
Minimum balloon/device surface-skin distance of 5 mm |
| 4. |
V150 ≤ 50 cc |
| 5. |
V200 ≤ 10 cc |
You and your patients can be confident throughout the holidays as you have chosen the proven APBI treatment.
|
Learn about our Home for Holidays Promotion available thru December 22, 2011. Call your Territory Sales Specialist TODAY!
You have options in the ultrasound suite when it comes to breast biopsy. From full-vacuum with the ATEC® breast biopsy device, to a vacuum assisted spring-loaded core with the Celero® breast biopsy device, Hologic offers you tools to fit your patients'
needs.
Thousands of women have confronted the challenges of breast cancer & fought it with MammoSite. Connect your patients with these women and their impactful, heartwarming stories at Voices of MammoSite. |
